Precision Medicine Market - Top Companies and Manufacturers

In the News

• In May 2024, Novartis announced that it had agreed to acquire Mariana Oncology, a preclinical-stage biotechnology company based in Watertown, Massachusetts focused on developing novel radioligand therapies (RLTs) to treat cancers with high unmet patient need.
  The deal enhances the Novartis RLT pipeline and improves the company's research infrastructure and clinical supply capabilities, aligning with Novartis' strategy focus on oncology and RLT platform innovation. The acquisition includes a strong collection of RLT programs that cover lead optimization to early development in various solid tumor indications, such as breast, prostate, and lung cancer.
• In May 2024, QIAGEN announced the launch of its QIAseq Multimodal DNA/RNA Library Kit. The new kit enables seamless preparation of DNA and RNA libraries for next-generation sequencing (NGS), such as whole genome sequencing (WGS) and whole transcriptome sequencing (WTS), as well as downstream target enrichment based on hybrid capture from a single sample.